{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T18:41:17Z","timestamp":1793472077317,"version":"4.5.0"},"reference-count":42,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Open Heart"],"accepted":{"date-parts":[[2016,8,15]]},"published-print":{"date-parts":[[2016,9]]},"abstract":"<jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Hypertension is well established as a major risk factor for cardiovascular disease. Although there is undeniable evidence to support the beneficial effects of antihypertensive therapy on morbidity and mortality, adequate blood pressure management still remains suboptimal. Research into the treatment of hypertension has produced a multitude of drug classes with different efficacy profiles. These agents include \u03b2-blockers, diuretics, ACE inhibitors, angiotensin receptor blockers and calcium channel blockers. One of the oldest groups of antihypertensives, the calcium channel blockers are a heterogeneous group of medications.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This review paper will focus on amlodipine, a dihydropyridine calcium channel blockers, which has been widely used for 2 decades.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Amlodipine has good efficacy and safety, in addition to strong evidence from large randomised controlled trials for cardiovascular event reduction.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Amlodipine should be considered a first-line antihypertensive agent.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/openhrt-2016-000473","type":"journal-article","created":{"date-parts":[[2016,9,28]],"date-time":"2016-09-28T22:49:50Z","timestamp":1475102990000},"page":"e000473","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":133,"title":["Amlodipine in hypertension: a first-line agent with efficacy for improving blood pressure and patient outcomes"],"prefix":"10.1136","volume":"3","author":[{"given":"Hassan","family":"Fares","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute, Ochsner Clinical School-The University of Queensland School of Medicine, New Orleans, Louisiana, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J","family":"DiNicolantonio","sequence":"additional","affiliation":[{"name":"Saint Luke's Mid America Heart Institute, Kansas City, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H","family":"O'Keefe","sequence":"additional","affiliation":[{"name":"Saint Luke's Mid America Heart Institute, Kansas City, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl J","family":"Lavie","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute, Ochsner Clinical School-The University of Queensland School of Medicine, New Orleans, Louisiana, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2016,9,28]]},"reference":[{"key":"2025081710201364000_3.2.e000473.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2007.01.016"},{"key":"2025081710201364000_3.2.e000473.2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(94)90271-2"},{"key":"2025081710201364000_3.2.e000473.3","doi-asserted-by":"publisher","DOI":"10.1159\/000175050"},{"key":"2025081710201364000_3.2.e000473.4","doi-asserted-by":"publisher","DOI":"10.1038\/ajh.2008.216"},{"key":"2025081710201364000_3.2.e000473.5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.18.2217"},{"key":"2025081710201364000_3.2.e000473.6","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2010.237"},{"key":"2025081710201364000_3.2.e000473.7","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1253\/circj.70.124","article-title":"Effect of losartan and amlodipine on left ventricular diastolic function in patients with mild-to-moderate hypertension (J-ELAN): rationale and design","volume":"70","author":"J-ELAN Investigators","year":"2006","journal-title":"Circ J"},{"key":"2025081710201364000_3.2.e000473.8","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcg123"},{"key":"2025081710201364000_3.2.e000473.9","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000093242.48333.3B"},{"key":"2025081710201364000_3.2.e000473.10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.23.2981"},{"key":"2025081710201364000_3.2.e000473.11","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/28.11.1720"},{"key":"2025081710201364000_3.2.e000473.12","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(00)01297-8"},{"key":"2025081710201364000_3.2.e000473.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjhyper.2004.05.025"},{"key":"2025081710201364000_3.2.e000473.14","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(99)00091-7"},{"key":"2025081710201364000_3.2.e000473.15","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.28.689"},{"key":"2025081710201364000_3.2.e000473.16","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16451-9"},{"key":"2025081710201364000_3.2.e000473.17","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1097\/01.hjh.0000234122.55895.5b","article-title":"Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trial","volume":"24","author":"Kjeldsen","year":"2006","journal-title":"J Hypertens"},{"key":"2025081710201364000_3.2.e000473.18","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.21.4.597"},{"key":"2025081710201364000_3.2.e000473.19","doi-asserted-by":"publisher","DOI":"10.1177\/1074248410395018"},{"key":"2025081710201364000_3.2.e000473.20","doi-asserted-by":"crossref","first-page":"2M","DOI":"10.1016\/S0002-9149(01)02108-7","article-title":"Mechanisms of atherosclerotic plaque stabilization for a lipophilic calcium antagonist amlodipine","volume":"88","author":"Mason","year":"2001","journal-title":"Am J Cardiol"},{"key":"2025081710201364000_3.2.e000473.21","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.97.6.576"},{"key":"2025081710201364000_3.2.e000473.22","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5273(97)00239-8"},{"key":"2025081710201364000_3.2.e000473.23","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.11.5478"},{"key":"2025081710201364000_3.2.e000473.24","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.13.1503"},{"key":"2025081710201364000_3.2.e000473.25","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(01)00729-8"},{"key":"2025081710201364000_3.2.e000473.26","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2012.670636"},{"key":"2025081710201364000_3.2.e000473.27","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)62100-0"},{"key":"2025081710201364000_3.2.e000473.28","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.83.1.52"},{"key":"2025081710201364000_3.2.e000473.29","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.82.6.1954"},{"key":"2025081710201364000_3.2.e000473.30","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(87)80135-3"},{"key":"2025081710201364000_3.2.e000473.31","first-page":"1593","article-title":"Reducing readmissions for congestive heart failure","volume":"63","author":"Hoyt","year":"2001","journal-title":"Am Fam Physician"},{"key":"2025081710201364000_3.2.e000473.32","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(98)00496-2"},{"key":"2025081710201364000_3.2.e000473.33","doi-asserted-by":"publisher","DOI":"10.1016\/S1388-9842(00)00080-5"},{"key":"2025081710201364000_3.2.e000473.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2013.04.004"},{"key":"2025081710201364000_3.2.e000473.35","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0806182"},{"key":"2025081710201364000_3.2.e000473.36","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67185-1"},{"key":"2025081710201364000_3.2.e000473.37","first-page":"455","article-title":"Optimizing combination therapy for cardiovascular protection: evidence from landmark trials","volume":"35","author":"Clavreul","year":"2013","journal-title":"Medicographia"},{"key":"2025081710201364000_3.2.e000473.38","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/j.clinthera.2008.09.008","article-title":"An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine\/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine\/ramipril (ATAR) study","volume":"30","author":"Miranda","year":"2008","journal-title":"Clin Ther"},{"key":"2025081710201364000_3.2.e000473.39","doi-asserted-by":"publisher","DOI":"10.3317\/jraas.2007.023"},{"key":"2025081710201364000_3.2.e000473.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2008.04.002"},{"key":"2025081710201364000_3.2.e000473.41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-7176.2011.00468.x"},{"key":"2025081710201364000_3.2.e000473.42","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.109.131300"}],"container-title":["Open Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/openhrt-2016-000473","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T17:20:22Z","timestamp":1755451222000},"score":1,"resource":{"primary":{"URL":"https:\/\/openheart.bmj.com\/lookup\/doi\/10.1136\/openhrt-2016-000473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":42,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,9,28]]},"published-print":{"date-parts":[[2016,9]]}},"alternative-id":["10.1136\/openhrt-2016-000473"],"URL":"https:\/\/doi.org\/10.1136\/openhrt-2016-000473","relation":{},"ISSN":["2053-3624"],"issn-type":[{"value":"2053-3624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9]]}}}